US2003147979A1PendingUtilityA1

Ligand for peroxisome proliferator-activated receptor

43
Priority: Oct 23, 2001Filed: Oct 23, 2002Published: Aug 7, 2003
Est. expiryOct 23, 2021(expired)· nominal 20-yr term from priority
Inventors:Tatsumasa MaeMisuzu TsukagawaHideyuki KishidaMitsuaki KitanoMikio KitaharaKaku NakagawaMinpei KurodaYoshihiro MimakiYutaka Sashida
A61P 3/10A61P 43/00A61P 3/04A23K 50/40A23L 33/105A23K 20/111A23L 27/60A21D 2/14A23D 7/0056A23L 7/109A23D 9/007A61K 31/00A61K 31/12
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The object of the present invention is to provide PPARγ ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPARγ ligand as an active agent. The present invention relates to a ligand for peroxisome proliferator-activated receptor which comprises curcumin or its derivatives. The composition according to the present invention, which comprises the PPARγ ligand as an active agent is useful for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity.

Claims

exact text as granted — not AI-modified
What we claim is:  
     
         1 . A ligand for peroxisome proliferator-activated receptor 
 which comprises curcumin or its derivative.    
     
     
         2 . The ligand for peroxisome proliferator-activated receptor according to  claim 1 , 
 wherein said peroxisome proliferator-activated receptor is a peroxisome proliferator-activated receptor γ.    
     
     
         3 . A composition for preventing and/or improving Insulin Resistance Syndrome, 
 which comprises at least one selected from the group consisting of curcumin and its derivatives as an active agent.    
     
     
         4 . A composition for preventing and/or improving diabetes mellitus, 
 which comprises at least one selected from the group consisting of curcumin and its derivatives as an active agent.    
     
     
         5 . A composition for preventing and/or improving obesity or visceral fat obesity, 
 which comprises at least one selected from the group consisting of curcumin and its derivatives as an active agent.    
     
     
         6 . The composition according to any of  claims 3  to  5 , 
 which is applicable for foods and drinks.  
 
     
     
         7 . The composition according to any of  claims 3  to  5 , 
 which is applicable for pharmaceuticals.  
 
     
     
         8 . The composition according to any of  claims 3  to  5 , 
 which can be given to domestic animals or pets.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.